CPCLX
Price
$15.59
Change
-$0.12 (-0.76%)
Updated
Jun 2 closing price
Net Assets
1.11B
LEQCX
Price
$10.31
Change
+$0.02 (+0.19%)
Updated
Jun 2 closing price
Net Assets
30.75M
Interact to see
Advertisement

CPCLX vs LEQCX

Header iconCPCLX vs LEQCX Comparison
Open Charts CPCLX vs LEQCXBanner chart's image
CPCLX vs LEQCX Comparison Chart in %
View a ticker or compare two or three
VS
CPCLX vs. LEQCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPCLX is a Buy and LEQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CPCLX has more cash in the bank: 1.11B vs. LEQCX (30.8M). LEQCX pays higher dividends than CPCLX: LEQCX (0.63) vs CPCLX (0.53). CPCLX was incepted earlier than LEQCX: CPCLX (10 years) vs LEQCX (13 years). LEQCX (3.67) is less costly to investors than CPCLX (3.05). LEQCX is a more actively managed with annual turnover of: 1506.00 vs. CPCLX (347.00). CPCLX (2500) and LEQCX (2500) have matching initial minimum investment requirements. CPCLX annual gain was more profitable for investors over the last year : -1.80 vs. LEQCX (-6.35). CPCLX return over 5 years is better than : 3.93 vs. LEQCX (-15.31).
CPCLXLEQCXCPCLX / LEQCX
Total Expense Ratio3.053.3591%
Annual Report Gross Expense Ratio3.053.6783%
Fund Existence10 years13 years-
Gain YTD-0.7015.755-12%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B30.8M3,588%
Annual Yield % from dividends0.530.6384%
Returns for 1 year-1.80-6.3528%
Returns for 3 years11.310.851,328%
Returns for 5 years3.93-15.31-26%
Returns for 10 years56.454.101,378%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRMTX137.44N/A
N/A
T. Rowe Price Comm & Tech Investor
LAVFX16.60N/A
N/A
Lord Abbett Fundamental Equity F
RLSIX15.37N/A
N/A
RiverPark Long/Short Opportunity Instl
MSPRX23.97N/A
N/A
Morgan Stanley Inst Advantage C
QTERX16.84N/A
N/A
AQR Emerging Multi-Style II R6